John Hoekman - Apr 27, 2021 Form 4/A - Amendment Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Apr 27, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/7/2021, 04:57 PM
Date Of Original Report
Apr 29, 2021
Next filing
Jul 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMPL Common Stock Conversion of derivative security $0 +4.25K +4.08% $0.00 108K Apr 27, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Series A-2 Preferred Stock Conversion of derivative security $0 -69.7K -100% $0.00* 0 Apr 27, 2021 Common Stock 4.25K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed solely to correct an inadvertent error in the number of shares of common stock acquired in connection with the conversion of shares of Series A-2 Preferred Stock held by the reporting person from 4,523 shares to 4,253 shares.
F2 The shares of the issuer's Series A-2 Preferred Stock automatically converted on a 16.37332-for-one basis into shares of the issuer's Common Stock on April 27, 2021 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-254999) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.